A Prospective Observational study to describe the pattern andeffectiveness of the utilization of different treatment options forMetastatic Renal Cell Carcinoma (OPERA)

Description :
This is a regional, multicenter observational prospective study, to obtain routine clinical practice data on the usage patterns andoutcomes (safety and effectiveness) of immunotherapy and/orTKI, for metastatic renal cell carcinoma in real-life practice.One hundred eighty-five patients diagnosed with metastatic renalcell carcinoma and will start on immunotherapy and/or TKI in thisobservational study. Data on efficacy and safety will be recordedat different time-points: at baseline, during treatment at 4 weeks,3, 6, 12 and 36 months, and at every follow-up once yearly afterthe last administration of immunotherapy and TKI until lastfollow-up, patient death, or data collection cut off point.

Titulaire :
GHOSN Marwan

Contact USJ :
marwan.ghosn@usj.edu.lb

Chercheur(s) :
Pr Marwan GHOSN

Projet présenté au CR, le : 01/07/2021

Projet achevé auprès du CR : 01/01/2025